These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
768 related items for PubMed ID: 16938406
1. C57BL/6J mice exhibit reduced dopamine D3 receptor-mediated locomotor-inhibitory function relative to DBA/2J mice. McNamara RK, Levant B, Taylor B, Ahlbrand R, Liu Y, Sullivan JR, Stanford K, Richtand NM. Neuroscience; 2006 Nov 17; 143(1):141-53. PubMed ID: 16938406 [Abstract] [Full Text] [Related]
2. Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague-Dawley rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/2J mice. Ralph RJ, Caine SB. J Pharmacol Exp Ther; 2005 Feb 17; 312(2):733-41. PubMed ID: 15494551 [Abstract] [Full Text] [Related]
3. Behavioral and cellular dopamine D1 and D3 receptor-mediated synergy: Implications for L-DOPA-induced dyskinesia. Lanza K, Meadows SM, Chambers NE, Nuss E, Deak MM, Ferré S, Bishop C. Neuropharmacology; 2018 Aug 17; 138():304-314. PubMed ID: 29936243 [Abstract] [Full Text] [Related]
4. Inhibitory control and response latency differences between C57BL/6J and DBA/2J mice in a Go/No-Go and 5-choice serial reaction time task and strain-specific responsivity to amphetamine. Loos M, Staal J, Schoffelmeer AN, Smit AB, Spijker S, Pattij T. Behav Brain Res; 2010 Dec 25; 214(2):216-24. PubMed ID: 20580749 [Abstract] [Full Text] [Related]
5. Reciprocal cross-sensitization of D1 and D3 receptors following pharmacological stimulation in the hemiparkinsonian rat. Lanza K, Chemakin K, Lefkowitz S, Saito C, Chambers N, Bishop C. Psychopharmacology (Berl); 2020 Jan 25; 237(1):155-165. PubMed ID: 31435690 [Abstract] [Full Text] [Related]
7. A functional role for the dopamine D3 receptor in the induction and expression of behavioural sensitization to ethanol in mice. Harrison SJ, Nobrega JN. Psychopharmacology (Berl); 2009 Nov 25; 207(1):47-56. PubMed ID: 19662386 [Abstract] [Full Text] [Related]
8. Mouse strain differences in locomotor, sensitisation and rewarding effect of heroin; association with alterations in MOP-r activation and dopamine transporter binding. Bailey A, Metaxas A, Al-Hasani R, Keyworth HL, Forster DM, Kitchen I. Eur J Neurosci; 2010 Feb 25; 31(4):742-53. PubMed ID: 20384817 [Abstract] [Full Text] [Related]
9. Dopamine D3 receptor binding of (18)F-fallypride: Evaluation using in vitro and in vivo PET imaging studies. Mukherjee J, Constantinescu CC, Hoang AT, Jerjian T, Majji D, Pan ML. Synapse; 2015 Dec 25; 69(12):577-91. PubMed ID: 26422464 [Abstract] [Full Text] [Related]
10. The Dopamine Receptor D3 Regulates Lipopolysaccharide-Induced Depressive-Like Behavior in Mice. Wang J, Jia Y, Li G, Wang B, Zhou T, Zhu L, Chen T, Chen Y. Int J Neuropsychopharmacol; 2018 May 01; 21(5):448-460. PubMed ID: 29390063 [Abstract] [Full Text] [Related]
11. Differential susceptibility to ethanol and amphetamine sensitization in dopamine D3 receptor-deficient mice. Harrison SJ, Nobrega JN. Psychopharmacology (Berl); 2009 May 01; 204(1):49-59. PubMed ID: 19096829 [Abstract] [Full Text] [Related]
12. Dose-response analysis of locomotor activity and stereotypy in dopamine D3 receptor mutant mice following acute amphetamine. McNamara RK, Logue A, Stanford K, Xu M, Zhang J, Richtand NM. Synapse; 2006 Oct 01; 60(5):399-405. PubMed ID: 16856172 [Abstract] [Full Text] [Related]
13. Effect of dopamine D3 antagonists on PPI in DBA/2J mice or PPI deficit induced by neonatal ventral hippocampal lesions in rats. Zhang M, Ballard ME, Kohlhaas KL, Browman KE, Jongen-Rêlo AL, Unger LV, Fox GB, Gross G, Decker MW, Drescher KU, Rueter LE. Neuropsychopharmacology; 2006 Jul 01; 31(7):1382-92. PubMed ID: 16395300 [Abstract] [Full Text] [Related]
14. Biased G Protein-Independent Signaling of Dopamine D1-D3 Receptor Heteromers in the Nucleus Accumbens. Guitart X, Moreno E, Rea W, Sánchez-Soto M, Cai NS, Quiroz C, Kumar V, Bourque L, Cortés A, Canela EI, Bishop C, Newman AH, Casadó V, Ferré S. Mol Neurobiol; 2019 Oct 01; 56(10):6756-6769. PubMed ID: 30919214 [Abstract] [Full Text] [Related]
15. Dopamine in the medial prefrontal cortex controls genotype-dependent effects of amphetamine on mesoaccumbens dopamine release and locomotion. Ventura R, Alcaro A, Cabib S, Conversi D, Mandolesi L, Puglisi-Allegra S. Neuropsychopharmacology; 2004 Jan 01; 29(1):72-80. PubMed ID: 12968132 [Abstract] [Full Text] [Related]
16. Dopamine receptors modulate cytotoxicity of natural killer cells via cAMP-PKA-CREB signaling pathway. Zhao W, Huang Y, Liu Z, Cao BB, Peng YP, Qiu YH. PLoS One; 2013 Jan 01; 8(6):e65860. PubMed ID: 23799052 [Abstract] [Full Text] [Related]
17. In vitro and in vivo characterization of the agonist-dependent D3 dopamine receptor tolerance property. Cote SR, Kuzhikandathil EV. Neuropharmacology; 2014 Apr 01; 79():359-67. PubMed ID: 24316466 [Abstract] [Full Text] [Related]
18. Strain-specific proportion of the two isoforms of the dopamine D2 receptor in the mouse striatum: associated neural and behavioral phenotypes. Colelli V, Fiorenza MT, Conversi D, Orsini C, Cabib S. Genes Brain Behav; 2010 Oct 01; 9(7):703-11. PubMed ID: 20546314 [Abstract] [Full Text] [Related]
19. Genotypic differences in brain dopamine receptor function in the DBA/2J and C57BL/6J inbred mouse strains. Ng GY, O'Dowd BF, George SR. Eur J Pharmacol; 1994 Nov 15; 269(3):349-64. PubMed ID: 7895774 [Abstract] [Full Text] [Related]
20. [A comparative genetic analysis of the role of the brain dopaminergic systems in the regulation of behavioral elements in the "open field" test in DBA/2J and C57BL/6J mice]. Kuligina ESh, Lebedev AA, Luchnikova EM. Genetika; 1997 Nov 15; 33(11):1529-33. PubMed ID: 9480216 [Abstract] [Full Text] [Related] Page: [Next] [New Search]